L. Lo

A Phase 1 Study of Mapatumumab (Fully Human Monoclonal Antibody to TRAIL-R1) in Patients with Advanced Solid Malignancies

A. Oza, H. Hirte, L. Siu, 2008, Clinical Cancer Research.

Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

M. Chonchol, S. Fishbane, P. Pergola, 2020, Journal of the American Society of Nephrology : JASN.

Raxibacumab for the treatment of inhalational anthrax.

S. Ullrich, J. Mott, T. Migone, 2009, The New England journal of medicine.

A dual apolipoprotein C-II mimetic–apolipoprotein C-III antagonist peptide lowers plasma triglycerides

R. Pastor, Soumitra S Ghosh, S. Neher, 2020, Science Translational Medicine.

Abstract 13727: Effects of Ziltivekimab (ZILTI), a Novel Anti-Interleukin-6 Monoclonal Antibody, on Markers of Inflammation and Cardiovascular Risk in Patients With Chronic Kidney Disease on Hemodialysis

M. Davidson, R. Kakkar, L. Lo, 2019 .

Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study

C. Zoccali, F. Mallamaci, C. Torino, 2019, Journal of clinical medicine.

The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation.

R. Siegel, T. Wynn, W. Strober, 2011 .